Alternatively spliced IS6 segments of the α(1C) gene determine the tissue-specific dihydropyridine sensitivity of cardiac and vascular smooth muscle L-type Ca2+ channels

Circulation Research

Volumn 81, Issue 4, 1997, Pages 526-532

  Welling, Andrea ^a,b,c   Ludwig, Andreas ^a,b,c   Zimmer, Stephanie ^a,b,c   Klugbauer, Norbert ^a,b,c   Flockerzi, Veit ^a,b,c   Hofmann, Franz ^a,b,c  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b SAARLAND UNIVERSITY   (Germany)

^c UNIVERSITY OF MUNICH   (Germany)

Author keywords

Ca2+ antagonist; Chimeric channel; Heart muscle; L type Ca2+ channel; Vascular smooth muscle

Indexed keywords

CALCIUM CHANNEL; CALCIUM ION; DIHYDROPYRIDINE DERIVATIVE; NISOLDIPINE;

ALTERNATIVE RNA SPLICING; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CALCIUM TRANSPORT; CHIMERA; HEART ELECTROPHYSIOLOGY; NONHUMAN; PRIORITY JOURNAL; RAT; TISSUE SPECIFICITY; VASCULAR SMOOTH MUSCLE;

EID: 0030792754     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.81.4.526     Document Type: Article

References (26)

1. 2+ channel diversity. Annu Rev Neurosci. 1994;17:399-418.
2. Mikami A, Imoto K, Tanabe T, Niidome T, Mori Y, Takeshima H, Narumiya S, Numa S. Primary structure and functional expression of the cardiac dihydropyridine-sensitive calcium channel. Nature. 1989;340:230-233.
3. Biel M, Ruth P, Bosse E, Hullin R, Stühmer P, Flockerzi V, Hofmann F. Primary structure and functional expression of high voltage activated calcium channel from rabbit lung. FEBS Lett. 1990;269:409-412.
4. Triggle DJ. Calcium-channel drugs: structure-function relationships and selectivity of action. J Cardiovasc Pharmacol. 1991; 18:S1-S6.
5. Bean BP. Nitrendipine block of cardiac calcium channels: high-affinity binding to the inactivated state. Proc Natl Acad Sci USA. 1984;81:6388-6392.
6. Sanguinetti MC, Kass RS. Voltage-dependent block of calcium channel current in calf cardiac Purkinje fiber by dihydropyridine calcium channel antagonists. Circ Res. 1984;55:336-348.
7. Nelson MT, Laher I, Worley J. Membrane potential regulates dihydropyridine inhibition of single calcium channels and contraction of rabbit mesenteric artery. In: Vanhoutle PM, Paoletti R, Govoni S, eds. Calcium Antagonists: Pharmacology and Clinical Research. New York, NY: New York Academy of Science; 1988:47-50.
8. Welling A, Kwan YW, Bosse E, Flockerzi V, Hofmann F, Kass RS. Subunit-dependent modulation of recombinant L-type calcium channels: molecular basis for dihydropyridine tissue selectivity. Circ Res. 1993;73:974-980.
9. Seisenberger C, Welling A, Schuster A, Hofmann F. Two stable cell lines for screening of calcium channel blockers. Naunyn Schmiedebergs Arch Pharmacol. 1995;352:662-669.
10. 2+ channel splice variants. J Biol Chem. 1995;270:10540-10543.
11. 3H]azidopine within the α1, subunit. Proc Natl Acad Sci U S A. 1991;88:10769-10773.
12. Kalasz H, Watanabe T, Yabana H, Itagaki K, Naito K, Nakayama H, Schwartz A, Vaghy PL. Identification of 1,4-dihydropyridine binding domains within the primary structure of the α1, subunit of the skeletal muscle L-type calcium channel. FEBS Lett. 1993;331: 177-181.
13. Grabner M, Wang Z, Hering, S, Striessnig J, Glossmann H. Transfer of 1,4-dihydropyridine sensitivity from L-type to class A (B1) calcium channels. Neuron. 1996;16:207-218.
14. Peterson BZ, Tanada TN, Catterall WA. Molecular determinants of high affinity dihydropyridine binding in L-type calcium channels. J Biol Chem. 1996;271:5293-5296.
15. Schuster A, Lacinová, L, Klugbauer N, Ito H, Birnbaumer L, Hofmann F. The IVS6 segment of the L-type calcium channel is critical for the action of dihydropyridines and phenylalkylamines. EMBO J. 1996;15:2365-2370.
16. Mitterdorfer J, Wang Z, Sinnegger MJ, Hering S, Striessnig J, Grainier M, Glossmann H. Two amino acid residues in the IIIS5 segment of L-type calcium channels differentially contribute to 1,4-dihydropyridine sensitivity. J Biol Chem. 1996;271:30330-30335.
17. He M, Bodi I, Mikala G, Schwartz A. Motif III S5 of L-type calcium channels is involved in the dihydropyridine binding site: a combined radioligand binding and electrophysiological study. J Biol Chem. 1997;272:2629-2633.
18. Ito H, Klugbauer N, Hofmann F. Transfer of the high-affinity dihydropyridine sensitivity from L-type to non-L-type calcium channel. Mol. Pharmacol. In press.
19. Zong X, Schreieck J, Mehrke G, Welling A, Schuster A, Bosse E, Flockerzi V, Hofmann F. On the regulation of the expressed L-type calcium channel by cAMP-dependent protein kinase. Pflugers Arch. 1995;430:340-347.
20. 1, subunit. J Biol Chem. 1994;269:1635-1640.
21. Snutch TP, Tomlinson WJ, Leonard JP, Gilbert MM. Distinct calcium channels are generated by alternative splicing and are differentially expressed in the mammalian CNS. Neuron. 1991;7: 45-57.
22. Hofmann F, Klugbauer N, Lacinová L, Seisenberger C, Schuster A, Welling A. Interaction of the L-type calcium channel with calcium channel blockers. In: Endoh M, Iijima T, Morad M, Scholz H, eds. Molecular and Cellular Mechanisms of Cardiovascular Regulation. New York, NY: Springer Verlag; 1996:231-242.
23. Hofmann F, Biel M, Bosse E, Flockerzi V, Ruth P, Welling A. Functional expression of cardiac and smooth muscle calcium channels. In: Brown AM, Catterall WA, Kaczorowski GJ, Spooner PS, Strauss HC, eds. Ion Channels in the Cardiovascular Systems: Function and Dysfunction. Armonk, NY: Futura Publishing Co; 1994:369-381.
24. 1 subunit enhances secretion from adrenal chromaffin cells. J Biol Chem. 1992;267:22728-22732.
25. Zhang J, Ellinor PT, Aldrich RW, Tsien RW. Molecular determinants of voltage-dependent inactivation in calcium channels. Nature. 1994;372:97-100.
26. Parent L, Gopalakrishnan M, Lacerda AE, Wei X, Perez-Reyes E. Voltage-dependent inactivation in a cardiac-skeletal chimeric calcium channel. FEBS Lett. 1995;360:144-150.